Diagnostic yield and safety of endoscopic-ultrasound guided trucut biopsy in patients with gastric submucosal tumors: a prospective study

Marcin Polkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), E Butruk(Foundation for Polish Science), Zbigniew Nowecki(The Maria Sklodowska-Curie National Research Institute of Oncology), Jarosław Reguła(The Maria Sklodowska-Curie National Research Institute of Oncology), W Gerke(Postgraduate School of Molecular Medicine), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), D. Jarosz(Postgraduate School of Molecular Medicine), W. Ruka(The Maria Sklodowska-Curie National Research Institute of Oncology), Anna Nasierowska‐Guttmejer(Jan Kochanowski University)
Endoscopy
April 1, 2009
10.1055/s-0029-1214447
Cited by 128

Related Papers

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
|The Lancet|2012|3k
Quality Indicators for Colonoscopy and the Risk of Interval Cancer
|New England Journal of Medicine|2010|2k
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
|The Lancet|2020|1.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
|The Lancet|2012|1.4k